Imeros

Mepivacaine Hydrochloride, the active ingredient in Imeros, is a local anesthetic presented as a sterile injectable solution for infiltration and perineural use. It provides reversible nerve blockade for dental and surgical procedures.\n\nGNH India supplies Imeros as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imeros is a local anesthetic used to achieve temporary loss of sensation in targeted tissues for dental and surgical interventions.\n\nDental procedures: provides local anesthesia for tooth extractions, periodontal surgery and other oral procedures.\nSurgical procedures: enables regional or infiltration anesthesia for minor to moderate surgical operations.\nPeripheral nerve blocks: facilitates perineural anesthesia for limb or trunk surgeries.

Mepivacaine may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Transient numbness or tingling at the injection site\n- Mild pain or burning sensation during injection\n- Dizziness or light‑headedness\n- Headache\n- Metallic taste\n- Local swelling or erythema\n\nSerious or Rare Side Effects:\n- Allergic reactions including anaphylaxis\n- Cardiovascular toxicity such as arrhythmias or cardiac arrest\n- Central nervous system toxicity leading to seizures\n- Prolonged or profound nerve block\n- Methemoglobinemia\n- Severe hypotension

When using Imeros, clinicians should observe several safety measures to minimize risk.\n\nAllergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.\nCardiovascular status: use with caution in patients with heart block or severe conduction disorders.\nDosage limits: adhere to recommended maximum dose based on patient weight and procedure.\nConcurrent medications: avoid co‑administration with Class I antiarrhythmics when possible.\nPregnancy considerations: safety not established; weigh benefits against potential risks.\nStore at room temperature: keep in original container, protect from light and moisture.

Mepivacaine can interact with other drugs, altering its safety profile.\n\nMajor Interactions (Avoid):\n- Class I antiarrhythmic agents (e.g., quinidine, procainamide): increase cardiotoxicity.\n- Beta‑adrenergic blockers: may potentiate hypotensive effects.\n- Monoamine oxidase inhibitors: risk of prolonged anesthesia.\n\nModerate Interactions (Monitor Closely):\n- Other local anesthetics: additive neuro‑ and cardiotoxicity.\n- Lithium: may enhance central nervous system toxicity.\n- Corticosteroids injected nearby: may affect absorption and duration.